Cargando…

Anti-Inflammatory Effects of Fargesin on Chemically Induced Inflammatory Bowel Disease in Mice

Fargesin is a bioactive lignan from Flos Magnoliae, an herb widely used in the treatment of allergic rhinitis, sinusitis, and headache in Asia. We sought to investigate whether fargesin ameliorates experimental inflammatory bowel disease (IBD) in mice. Oral administration of fargesin significantly a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Bei, Ren, Yi-Jing, Zhang, Jing-Jing, Luo, Xiao-Ping, Yu, Zhi-Lun, Ren, Gai-Yan, Sun, A-Ning, Deng, Chao, Wang, Zheng-Tao, Dou, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100621/ https://www.ncbi.nlm.nih.gov/pubmed/29880739 http://dx.doi.org/10.3390/molecules23061380

Ejemplares similares

Activation of PXR by Alpinetin Contributes to Abrogate Chemically Induced Inflammatory Bowel Disease
por: Yu, Zhilun, et al.
Publicado: (2020)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Flos magnoliae constituent fargesin has an anti-allergic effect via ORAI1 channel inhibition
por: Hong, Phan Thi Lam, et al.
Publicado: (2021)

Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancer
por: Luo, Xiaoping, et al.
Publicado: (2020)

Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
por: Lu, Jiansen, et al.
Publicado: (2021)

Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota
por: Ren, Junyu, et al.
Publicado: (2021)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
por: Lun, Jie, et al.
Publicado: (2023)

Chemical Constituents of Thesium chinense Turcz and Their In Vitro Antioxidant, Anti-Inflammatory and Cytotoxic Activities
por: Liu, Zhen-Zhen, et al.
Publicado: (2023)

Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System
por: Yue, Bei, et al.
Publicado: (2019)

Effects of emodin on inflammatory bowel disease-related osteoporosis
por: Luo, Jing-sheng, et al.
Publicado: (2020)

Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes
por: Kim, Ju-Hyun, et al.
Publicado: (2017)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
por: Klein, Amir, et al.
Publicado: (2010)

Chemical constituents and anti-inflammatory activities of Maqian (Zanthoxylum myriacanthum var. pubescens) bark extracts
por: Zhang, Huan-li, et al.
Publicado: (2017)

Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017
por: Qiu, Yan, et al.
Publicado: (2020)

Periodontitis and inflammatory bowel disease: a meta-analysis
por: She, Yang-yang, et al.
Publicado: (2020)

Chemical Constituents of Vigna luteola and Their Anti-inflammatory Bioactivity
por: Lam, Sio-Hong, et al.
Publicado: (2019)

Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway
por: Lee, Ga-Eun, et al.
Publicado: (2021)

Chemical Constituents of Hedyotis diffusa and Their Anti-Inflammatory Bioactivities
por: Hung, Hsin-Yi, et al.
Publicado: (2022)

Molecular mechanisms of the chemical constituents from anti-inflammatory and antioxidant active fractions of Ganoderma neo-japonicum Imazeki
por: Zhang, Rui-rui, et al.
Publicado: (2023)

Sodium fluoride induces renal inflammatory responses by activating NF-κB signaling pathway and reducing anti-inflammatory cytokine expression in mice
por: Luo, Qin, et al.
Publicado: (2017)

Changing paradigms in management of inflammatory bowel disease
por: Mao, Ren, et al.
Publicado: (2022)

A network pharmacology approach to establish the pharmacological mechanism of JiaWeiXianJiTang on inflammatory bowel disease
por: Tao, Ling-Jia, et al.
Publicado: (2017)

Effects of Deoxyschisandrin on Visceral Sensitivity of Mice with Inflammatory Bowel Disease
por: Xu, Zhili, et al.
Publicado: (2019)

Inflammatory bowel disease and bladder cancer risk: based on a Mendelian randomization study
por: Wang, Li, et al.
Publicado: (2023)

The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease
por: Yan, Jun-bin, et al.
Publicado: (2020)

The anti-inflammatory and protective role of interleukin-38 in inflammatory bowel disease
por: Ohno, Masashi, et al.
Publicado: (2022)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Chemical Composition and the Cytotoxic, Antimicrobial, and Anti-Inflammatory Activities of the Fruit Peel Essential Oil from Spondias pinnata (Anacardiaceae) in Xishuangbanna, Southwest China
por: Li, Ren, et al.
Publicado: (2020)

Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease
por: Liu, Ping, et al.
Publicado: (2021)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease
por: Chen, Yutong, et al.
Publicado: (2023)

PPAR-α Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
por: Esposito, Emanuela, et al.
Publicado: (2010)

Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease
por: Giuffrida, Paolo, et al.
Publicado: (2019)

Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases
por: Yu, Yunru, et al.
Publicado: (2021)

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine
por: Ning, Lijun, et al.
Publicado: (2023)

Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis
por: Yang, Qiyu, et al.
Publicado: (2022)

Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease
por: Yan, Peng-Guang, et al.
Publicado: (2020)

Role of Rho GTPases in inflammatory bowel disease
por: Li, Xiaoling, et al.
Publicado: (2023)

Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease
por: Wang, Shu-Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vsql4hui469juhg2f47plfri7f